 |
|
|
| |
Analysis of the longer-term safety profile of the hepatitis B virus core inhibitor ABI-H0731 in an open-label extension study
|
| |
| |
AASLD 2021 Nov 12-15
Ira M Jacobson1, Xiaoli Ma2, Tuan Nguyen3, Eugene R Schiff4, Man-Fung Yuen5, Hie-Won Hann6, Mark Sulkowski7, Ronald Nahass8,
Alnoor Ramji9, Kosh Agarwal10, James Park1, Walid Ayoub11, Edward Gane12, Steven J Knox13, Katia Alves13, Yunfeng Li13, Luisa M Stamm13, Frank Weilert14, Michael Bennett15, Steven-Huy Han16,
Natarajan Ravendhran17, Sing Chan18, Paul Kwo19, Magdy Elkhashab20, Tarek Hassanein21, Mauricio Bonacini22, Scott Fung23, Ho Bae24, Jacob Lalezari22, Douglas Dieterich25
1New York University Langone Medical Center, New York, NY, USA; 2Office of Xiaoli Ma, Philadelphia, PA, USA; 3T Nguyen Research and Education, Inc., San Diego, CA, USA; 4Schiff Center for Liver Diseases, University of Miami School of Medicine, Miami, FL, USA; 5Department of Medicine, The University of Hong Kong, Hong Kong; 6Thomas Jefferson University Hospital, Philadelphia, PA, USA; 7Johns Hopkins University School of Medicine, Baltimore, MD, USA; 8Infectious Disease Care, Hillsborough, NJ, USA; 9Providence Health Care Research Institute, Vancouver, Canada; 10Institute of Liver Studies, King's College Hospital, London, UK; 11Cedars-Sinai Medical Center, Los Angeles, CA, USA; 12Auckland Clinical Studies Ltd, Auckland, New Zealand; 13Assembly Biosciences, Inc, South San Francisco, CA, USA; 14Waikato Hospital, Hamilton, New Zealand; 15Medical Associates Research Group, San Diego, CA, USA; 16Pfleger Liver Institute, University of California, Los Angeles, CA, USA; 17Digestive Disease Associates, Catonsville, MD, USA; 18Sing Chan MD, New York, NY, USA; 19Stanford University Medical Center, Stanford, CA, USA; 20Toronto Liver Centre, Toronto, Canada; 21Southern California Research Center, Coronado, CA, USA; 22Quest Clinical Research, San Francisco, CA, USA; 23University of Toronto, Toronto, Canada; 24Asian Pacific Liver Center, Los Angeles, CA, USA;; 25Department of Medicine, Division of Liver Diseases, Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA
|
| |
|
|
|
|
|
